Research And Markets Research And Markets
0 CHECKOUT

Search for: "The 2010-2015 Outlook for Therapeutic Monoclonal Antibody (Mab)-Based Products in the United States"

Global Monoclonal Antibodies Market 2016-2020

About Monoclonal Antibodies Antibodies are the proteins produced by B-cells (in the bone marrow) in the immune system. These proteins attach themselves to antigens, which act as markers, and are...

Published:  July 2016
Price:  From EURUSDGBP

Monoclonal Antibody Based Products - Global Strategic Business Report

This report analyzes the worldwide markets for Monoclonal Antibody Based Products in Millions of US$. The major product segments and application areas analyzed are Therapeutics, and Diagnostics, especially...

Published:  October 2008
Price:  From EURUSDGBP

Global & USA Cancer Immunotherapy Market Analysis to 2020 - Updated Edition

Antibody Drug Conjugates (ADCs), Bispecific Monoclonal Antibodies, Cancer Vaccines, Cytokines, Interferons, Chimeric Antigen Receptor (CAR) T-Cell Therapy, PD-1/PD-L1 inhibitors, Dendritic Cells, Checkpoint...

Published:  July 2016
Price:  From EURUSDGBP
EURUSDGBP

Global Biosimilars Market, 2015 - 2025

Characterised by increased utility in chronic diseases and capital intensive manufacturing, the global biopharmaceutical market is expanding robustly. As the demand for biologics is increasing continuously,...

Published:  July 2015
Price:  From EURUSDGBP

Global Protein Therapeutics Market 2016-2020

Market outlook of the protein therapeutics market The market research analyst predicts the global protein therapeutics market to grow steadily at a CAGR of 8% during the forecast period. Increased...

Published:  November 2015
Price:  From EURUSDGBP

Antibody Drug Conjugates Market (3rd Edition)

The “Antibody Drug Conjugates Market (3rd edition), 2015-2025” report provides a comprehensive analysis of the current market landscape and future outlook of the growing pipeline of ADCs. The ADC market...

Published:  December 2015
Price:  From EURUSDGBP

What's Next in Biopharmaceuticals? (mAbs, rDNA, Interferons, and Other Upcoming Biologic Drugs) 2011-2015

The future of the pharmaceutical market will be determined by biologics - drugs produced by natural organisms or recombinant techniques consisting of proteins and other products derived from living...

Published:  May 2011
Price:  From EURUSDGBP

Prostate Cancer Therapeutics - Global Strategic Business Report

The report provides separate comprehensive analytics for the US, Canada, Europe, and Rest of World. Annual estimates and forecasts are provided for the period 2015 through 2022. Also, a six-year historic...

Published:  May 2016
Price:  From EURUSDGBP

Global Biosimilars Market 2016-2020

About Biosimilars Biosimilars are defined as the follow-on versions of original biological medicines. These are separately developed after the patent protecting the original product has expired. Biosimilars...

Published:  August 2016
Price:  From EURUSDGBP

Biopharmaceutical Bioseparation Systems - Global Strategic Analysis

This report analyzes the worldwide markets for Biopharmaceutical Bioseparation Systems in US$ Million by the following Product Segments: Chromatography Systems, and Other Bioseparation Systems. The...

Published:  February 2016
Price:  From EURUSDGBP

Biological Strategies in the Emerging Markets - BRIC Countries Will Underpin Future Pharma Growth

GBI Research, a leading business intelligence provider, has released its latest research “Biological Strategies in the Emerging Markets - BRIC Countries Will Underpin Future Pharma Growth” which examines...

Published:  June 2012
Price:  From EURUSDGBP

13th Annual Report and Survey Biopharmaceutical Manufacturing Capacity and Production

This report’s 492 pages of data-rich analysis will help improve your decision-making in biomanufacturing operations, with in-depth analysis of capacity, production trends, benchmarks, and much more. Coverage: -...

Published:  April 2016
Price:  From EURUSDGBP

PharmaPoint: Dyslipidemia - Global Drug Forecast and Market Analysis to 2023

PharmaPoint: Dyslipidemia - Global Drug Forecast and Market Analysis to 2023 Summary The publisher estimates that the total market size for the 8MM in 2013 was $15.4bn, comprised of $11.0bn in branded...

Published:  May 2015
Price:  From EURUSDGBP

PharmaPoint: Acute Coronary Syndrome - Global Drug Forecast and Market Analysis to 2023

PharmaPoint: Acute Coronary Syndrome - Global Drug Forecast and Market Analysis to 2023 Summary The publisher estimates that the total market size for the 7MM in 2013 was $12.3bn, comprised of $5.0bn...

Published:  July 2014
Price:  From EURUSDGBP
Loading Indicator